mesowatch
HomeCorporate Maneuvers Draw Scrutiny
divider

Corporate Maneuvers in Bankruptcy Cases Draw Scrutiny

image of senators chambers

In a gripping session before the Senate Judiciary Subcommittee on Tuesday, bankruptcy experts and individuals directly impacted by mass tort Chapter 11 cases laid bare their concerns over corporate strategies enabling large corporations to sidestep liability for asbestos exposure. The focus was on Johnson & Johnson’s recent deployment of the controversial “Texas two-step” tactic, sparking a fervent debate over the implications and potential remedies.

The hearing, chaired by Senator Sheldon Whitehouse of Rhode Island, delved into the intricacies of the Texas two-step strategy. Retired U.S. Bankruptcy Judge Judith K. Fitzgerald, now with Pittsburgh law firm Tucker Arensberg PC, elucidated how this method allows companies to shield assets while burdening subsidiaries with liabilities, ultimately leading to Chapter 11 filings.

The crux of the issue, as highlighted by Fitzgerald, lies in the exploitation of legal loopholes to evade accountability. Johnson & Johnson’s use of the Texas two-step to insulate itself from thousands of claims related to talc products underscores the magnitude of the problem.

Testimonies further underscored the human toll of such maneuvers. Kimberly A. Naranjo, a mesothelioma patient, lamented being deprived of her voice in seeking justice due to corporate machinations. Her poignant plea resonated with the committee, amplifying the urgency for action.

While proposals like banning bankruptcy filings post-Texas two-step transactions have been tabled, skepticism remains. University of Pennsylvania Law School professor David A. Skeel Jr. cautioned against hasty legislative measures, advocating for judicial discretion to discern bad faith filings.

Bankruptcy attorney Kevin C. Maclay minced no words, emphasizing the imperative for immediate intervention to curb corporate abuse of the system. His impassioned appeal for a “universal solution” struck a chord, urging Congress to stem the tide of injustice.

However, not all perspectives are aligned. Paul H. Zumbro of Cravath Swaine & Moore defended the legitimacy of Texas two-step cases, framing them as essential for managing mass tort liabilities efficiently. Amidst the fervor, the balance between fairness and expediency emerged as a central quandary.

As the hearing drew to a close, Senator Whitehouse vowed to navigate the murky waters of corporate accountability. The quest for a fair and equitable solution to combat corporate malfeasance looms large, signaling a pivotal moment in the fight for justice.

In the labyrinth of legal maneuvers, the voices of the afflicted echo with poignant urgency, compelling lawmakers to chart a course toward accountability and redemption.

Johnathan Edwards

Reading Time: 1 mins

Published On: February 8, 2022

Johnathan Edwards - author

Johnathan Edwards Is a husband, father, veteran and medical writer, from the state of California. After serving 9 years in the U.S Army Medical Department, John cultivated his passion for serving his country and helping people. He often volunteers with helping to rehabilitate veterans of all ages. After John’s father was diagnosed with Mesothelioma, he began to research, write and fight for ways to help other victims of asbestos exposure.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer